Skip to main content
Caplight Logo









Hemato.AI

Hemato.AI

Private
Bethesda, MarylandHealthcare & Life Scienceshttps://hemato.ai/

Last Round

Seed

Feb 27, 2025

Total Funding Raised

$7.6M

Company Overview

Hemato.AI is a health tech company that provides a cloud-based software service using artificial intelligence to analyze peripheral blood film images for the detection of hematological disorders.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS

AI Layer

Application

Keywords

hematopathologyblood smear analysisai diagnosticsmedical imaging AIdigital pathologypathology AIdiagnostic softwareperipheral blood filmSaaSclinical laboratory softwaremorphological anomaly detectionelectronic medical recordEMRusage-based billingmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Hemato.AI Comparables

Compare Hemato.AI with similar companies based on industry and business-model similarity.

Hemato.AI comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
hema.to
78%
Mantiscope
77%
Techcyte, Inc.
76%

Hemato.AI Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 27, 2025
SeedMay 1, 2023

Key People

Founding team and executive leadership

Vinodh Balaraman

Co-Founder & CEO (now Advisor)

Founding Team

Hemato.AI Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 27, 2025

    $4M round led by LUMO Labs.

Hemato.AI Filings

Explore SEC and related filing metadata, where available.

Hemato.AI filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Hemato.AI's valuation, stock price, and market status.

Is Hemato.AI a public or private company?

Hemato.AI is a private company.

What is the current stock price of Hemato.AI?

Hemato.AI is a private company with no public stock price. No recent secondary market data is available.

How much is Hemato.AI worth (valuation)?

Valuation information for Hemato.AI is not publicly available.

Can I buy Hemato.AI stock?

Hemato.AI shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Hemato.AI's last funding round?

Funding round information for Hemato.AI is not publicly available.

Who are the main investors in Hemato.AI?

Investor information for Hemato.AI is not publicly disclosed.

Will Hemato.AI IPO soon?

No public IPO plans have been announced for Hemato.AI.

How can I track Hemato.AI secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Hemato.AI's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBethesda, Maryland
Employee Range2
Year Founded2022
Last FundingFeb 27, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?